Suppr超能文献

七氟醚或安氟醚长时间麻醉对志愿者肾脏浓缩功能的影响

Renal concentrating function with prolonged sevoflurane or enflurane anesthesia in volunteers.

作者信息

Frink E J, Malan T P, Isner R J, Brown E A, Morgan S E, Brown B R

机构信息

Department of Anesthesiology, University of Arizona Health Sciences Center, Tucson 85724.

出版信息

Anesthesiology. 1994 May;80(5):1019-25. doi: 10.1097/00000542-199405000-00011.

Abstract

BACKGROUND

Sevoflurane, a new inhalational anesthetic, is biotransformed, producing peak plasma inorganic fluoride concentrations that may exceed 50 microM. We evaluated plasma inorganic fluoride concentrations with prolonged (> 9 MAC-h) sevoflurane or enflurane anesthesia in volunteers and compared renal concentrating function with desmopressin testing 1 and 5 days after anesthesia.

METHODS

Fourteen healthy male volunteers received either enflurane or sevoflurane (1-1.2 MAC) for more than 9 MAC-h. Each volunteer was administered three tests of renal concentrating function, with intranasal desmopressin and urine collections performed 1 week before anesthesia and 1 and 5 days after anesthesia. Venous blood samples were obtained for plasma fluoride concentrations during and after anesthesia. Creatinine clearance was determined by 24-h urine collections 7 days before and 4 days after anesthesia. Urine samples were obtained before and 1, 2, and 5 days after anesthesia for determination of n-acetyl-beta-glucosaminidase and creatinine concentrations.

RESULTS

Prolonged sevoflurane anesthesia (9.5 MAC-h) did not impair renal concentrating function on day 1 or 5 postanesthesia, as determined by desmopressin testing. Maximal urinary osmolality on day 1 postanesthesia was decreased (< 800 mOsm/kg) in two of seven enflurane-anesthetized volunteers; however, mean results did not differ from the those of the sevoflurane group. Mean peak plasma fluoride ion concentrations were 23 +/- 1 microM 6 h postanesthesia for enflurane and 47 +/- 3 microM at the end of anesthesia for sevoflurane (P < 0.01). There were no changes in creatinine clearance or urinary n-acetyl-beta-glucosaminidase concentration in either anesthetic group.

DISCUSSION

Prolonged sevoflurane anesthesia did not impair renal concentrating function, as evaluated with desmopressin testing 1 and 5 days postanesthesia in healthy volunteers. Although with prolonged enflurane anesthesia, mean maximal osmolality values on day 1 postanesthesia did not differ from sevoflurane values, there was evidence in two volunteers at this time point of impairment in renal concentrating function, which normalized 5 days postanesthesia. These results occurred despite a higher peak plasma fluoride ion concentration and greater total inorganic fluoride renal exposure with sevoflurane anesthesia.

摘要

背景

七氟烷是一种新型吸入麻醉剂,可发生生物转化,产生的血浆无机氟化物峰值浓度可能超过50微摩尔/升。我们评估了志愿者长时间(>9最低肺泡有效浓度小时)吸入七氟烷或恩氟烷麻醉后的血浆无机氟化物浓度,并在麻醉后1天和5天通过去氨加压素试验比较了肾脏浓缩功能。

方法

14名健康男性志愿者接受恩氟烷或七氟烷(1-1.2最低肺泡有效浓度)麻醉超过9最低肺泡有效浓度小时。每位志愿者在麻醉前1周以及麻醉后1天和5天接受三次肾脏浓缩功能测试,包括经鼻给予去氨加压素并收集尿液。在麻醉期间及麻醉后采集静脉血样以测定血浆氟化物浓度。通过麻醉前7天和麻醉后4天收集24小时尿液来测定肌酐清除率。在麻醉前以及麻醉后1天、2天和5天采集尿样以测定N-乙酰-β-氨基葡萄糖苷酶和肌酐浓度。

结果

通过去氨加压素试验测定,长时间七氟烷麻醉(9.5最低肺泡有效浓度小时)在麻醉后第1天或第5天并未损害肾脏浓缩功能。7名接受恩氟烷麻醉的志愿者中有2名在麻醉后第1天的最大尿渗透压降低(<800毫渗量/千克);然而,平均结果与七氟烷组并无差异。恩氟烷麻醉后6小时血浆氟离子峰值浓度平均为23±1微摩尔/升,七氟烷麻醉结束时为47±3微摩尔/升(P<0.01)。两个麻醉组的肌酐清除率或尿N-乙酰-β-氨基葡萄糖苷酶浓度均无变化。

讨论

在健康志愿者中,通过麻醉后1天和5天的去氨加压素试验评估,长时间七氟烷麻醉并未损害肾脏浓缩功能。虽然长时间恩氟烷麻醉后第1天的平均最大渗透压值与七氟烷组无差异,但在这个时间点有两名志愿者出现肾脏浓缩功能受损的证据,而在麻醉后5天恢复正常。尽管七氟烷麻醉时血浆氟离子峰值浓度更高且肾脏接触的总无机氟化物更多,但仍出现了这些结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验